UBL4A
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
ubiquitin like 4A | MIM:312070 | Ensembl:ENSG00000102178 | HGNC:HGNC:12505 | PA37152 | Xq28 |
GO terms in UBL4A
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
BP | TAS | GO:0006464 | cellular protein modification process |
BP | IDA | GO:0071816 | tail-anchored membrane protein insertion into ER membrane |
BP | IMP | GO:0071816 | tail-anchored membrane protein insertion into ER membrane |
CC | IDA | GO:0005634 | nucleus |
CC | IDA | GO:0005654 | nucleoplasm |
CC | IDA | GO:0005737 | cytoplasm |
CC | IDA | GO:0005829 | cytosol |
CC | IDA | GO:0016020 | membrane |
CC | IDA | GO:0071818 | BAT3 complex |
MF | IPI | GO:0005515 | protein binding |
MF | TAS | GO:0019787 | ubiquitin-like protein transferase activity |
MF | IPI | GO:0051087 | chaperone binding |
Gene expression in normal tissue: UBL4A
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in UBL4A
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD692 | SB590885 | 1 |
iGMDRD851 | BRD-K34222889 | 2 |
iGMDRD398 | Sepantronium | 2 |
iGMDRD145 | Omacetaxine mepesuccinate | 1 |
iGMDRD268 | Cerulenin | 2 |
iGMDRD454 | JNK Inhibitor VIII | 1 |
iGMDRD640 | CAY10618 | 2 |
iGMDRD94 | Narciclasine | 1 |
iGMDRD138 | PX 12 | 2 |
iGMDRD1037 | X1S.3R.RSL.3 | 2 |
iGMDRD309 | 17AAG | 2 |
iGMDRD847 | BRD-K26531177 | 1 |
iGMDRD649 | R428 | 1 |
iGMDRD203 | STF-31 | 1 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD498 | GW441756X | 1 |
iGMDRD107 | Valdecoxib | 1 |
iGMDRD732 | GSK2636771 | 1 |
iGMDRD697 | Methylstat | 2 |
iGMDRD866 | BRD1812 | 1 |
iGMDRD425 | ERASTIN | 2 |
iGMDRD112 | Methotrexate | 1 |
iGMDRD535 | SRT-1720 | 1 |
iGMDRD397 | Pazopanib | 1 |
iGMDRD1 | Nicotin-Amide | 1 |
iGMDRD670 | ML 210 | 2 |
iGMDRD144 | NSC95397 | 2 |
iGMDRD104 | Fingolimod | 1 |
iGMDRD42 | Vorinostat | 1 |
iGMDRD990 | PL.DI | 2 |
iGMDRD886 | Compound 1541A | 1 |
iGMDRD179 | Shikonin | 1 |
iGMDRD147 | Prima-1 | 2 |
iGMDRD157 | Ouabain | 1 |
iGMDRD467 | Motesanib | 1 |
iGMDRD121 | GMX1778 | 1 |
iGMDRD137 | Indisulam | 1 |
iGMDRD202 | Curcumin | 1 |
iGMDRD251 | ML162 | 2 |
iGMDRD208 | Necrosulfonamide | 2 |
iGMDRD504 | Obatoclax | 1 |
iGMDRD459 | RO-3306 | 1 |
iGMDRD267 | Oligomycin A | 2 |
iGMDRD77 | Itraconazole | 1 |
iGMDRD352 | PD-0325901 | 1 |
iGMDRD426 | WP1130 | 1 |
iGMDRD148 | Pifithrin-mu | 1 |
iGMDRD382 | CEP-701 | 1 |
iGMDRD798 | Ceranib-2 | 1 |
iGMDRD307 | Manumycin A | 2 |
iGMDRD256 | NVP-231 | 1 |
iGMDRD1036 | X17AAG | 1 |
iGMDRD703 | KPT185 | 1 |
iGMDRD614 | Dabrafenib | 3 |
iGMDRD125 | BIRB-796 | 1 |
iGMDRD321 | Daporinad | 1 |
iGMDRD299 | ICL 670 | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in UBL4A